1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity
- 1 January 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 120 (3) , 375-377
- https://doi.org/10.1016/0014-2999(86)90482-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Lack of evidence supporting a role for dopamine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicityEuropean Journal of Pharmacology, 1985
- Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the MouseJournal of Neurochemistry, 1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineEuropean Journal of Pharmacology, 1984
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- Tyrosine HydroxylaseJournal of Biological Chemistry, 1964
- TYROSINE HYDROXYLASE - INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS1964